HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6.

AbstractPURPOSE:
Age-related macular degeneration (AMD) is a retinal degenerative disease that is the leading cause of blindness worldwide for individuals over the age of 60. Although the etiology of AMD remains largely unknown, numerous studies have suggested that both genes and environmental risk factors significantly influence the risk of developing AMD. Identification of the underlying genes has been difficult, with both genomic screen (locational) and candidate gene (functional) approaches being used. The present study tested candidate genes for association with AMD.
METHODS:
Eight genes (alpha-2-macroglobulin [A2M], creatine kinase [CKB], angiotensin-converting enzyme [DCP1], interleukin-1alpha [IL1A], low-density lipoprotein receptor-related protein 6 [LRP6], microsomal glutathione-S-transferase 1 [MGST1], vascular entothelial growth factor [VEGF], and very low density lipoprotein receptor [VLDLR]) were tested for genetic linkage and allelic association, using two independent datasets: a family-based association dataset including 162 families and an independent case-control dataset with 399 cases and 159 fully evaluated controls.
RESULTS:
Test results suggested that genetic variation in five of these genes (IL1A, CKB, A2M, MGST1, and DCP1) is unlikely to explain a significant fraction of the risk of developing AMD in this population. LRP6 showed evidence both for linkage (heterogeneity lod [HLOD] = 1.14) in the family-based dataset and for association (P = 0.004) in the case-control dataset. VEGF showed evidence of linkage (HLOD = 1.32) and demonstrated significant independent allelic association in both the family-based (P = 0.001) and case-control (P = 0.02) datasets. VLDLR showed evidence of association in both the family based (P = 0.03) and case-control (P = 0.01) datasets.
CONCLUSIONS:
These data suggest that LRP6, VEGF, and VLDLR may play a role in the risk of developing AMD.
AuthorsJonathan L Haines, Nathalie Schnetz-Boutaud, Silke Schmidt, William K Scott, Anita Agarwal, Eric A Postel, Lana Olson, Shannon J Kenealy, Michael Hauser, John R Gilbert, Margaret A Pericak-Vance
JournalInvestigative ophthalmology & visual science (Invest Ophthalmol Vis Sci) Vol. 47 Issue 1 Pg. 329-35 (Jan 2006) ISSN: 0146-0404 [Print] United States
PMID16384981 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Interleukin-1
  • LRP6 protein, human
  • Low Density Lipoprotein Receptor-Related Protein-6
  • Receptors, LDL
  • VEGFA protein, human
  • VLDL receptor
  • Vascular Endothelial Growth Factor A
  • alpha-Macroglobulins
  • Glutathione Transferase
  • Creatine Kinase
  • Peptidyl-Dipeptidase A
Topics
  • Aged
  • Case-Control Studies
  • Creatine Kinase (genetics)
  • Female
  • Genetic Linkage
  • Genotype
  • Glutathione Transferase (genetics)
  • Humans
  • Interleukin-1 (genetics)
  • Low Density Lipoprotein Receptor-Related Protein-6
  • Macular Degeneration (genetics)
  • Male
  • Pedigree
  • Peptidyl-Dipeptidase A (genetics)
  • Polymorphism, Single Nucleotide
  • Receptors, LDL (genetics)
  • Risk Factors
  • Vascular Endothelial Growth Factor A (genetics)
  • alpha-Macroglobulins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: